Wiki Article

Photoreceptor cell-specific nuclear receptor

Nguồn dữ liệu từ Wikipedia, hiển thị bởi DefZone.Net

NR2E3
Identifiers
AliasesNR2E3, Nr2e3, A930035N01Rik, PNR, RNR, rd7, ESCS, RP37, nuclear receptor subfamily 2 group E member 3
External IDsOMIM: 604485; MGI: 1346317; GeneCards: NR2E3
Available structures
PDBOrtholog search: PDBe RCSB
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001281446
NM_014249
NM_016346

NM_013708

RefSeq (protein)

NP_055064
NP_057430

NP_038736

Location (UCSC)Chr 15: 71.79 – 71.82 MbChr 9: 59.85 – 59.87 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

NR2E3 (nuclear receptor subfamily 2, group E, member 3), also known as photoreceptor cell-specific nuclear receptor (PNR), is a protein that in humans is encoded by the NR2E3 gene.[5] PNR is a member of the nuclear receptor super family of intracellular transcription factors.

Function

[edit]

NR2E3 was initially cloned from human retinoblastoma Y79 cells [5] and a mouse λZAP eye cDNA library [6]in 1999. In addition to retinal photoreceptor cells, NR2E3 is expressed in many tissues such as the urogenital and respiratory systems in humans and mice, suggesting potential functions beyond the retina cells.[7] The main target genes of PNR as a transcription factor are rhodopsin and several opsins which are essential for sight.[8]

Since 2011, NR2E3 has been implicated in tumorigenesis through activating p53 as a transcriptional cofactor. NR2E3 enhances p53 acetylation via forming a complex of NR2E3-p300-p53.[9] NR2E3 mutants such as R76W and R97H, fail to activate p53.[7] Interstingly, NR2E3 rescues the wild-type activity of many mutated p53, including R175H hot-spot gain-of-function mutation.[10] Compound 11a, the agonist of NR2E3, has shown broad inhibitory effects on the cancer cells in NCI-60 cancer cell panel.[11] 11a stimulates NR2E3-mediated p53 activation while also activating NR2E1 and NR2F2 in a less degree.[7] The NR2E3-knock out mouse model suggests that NR2E3 may inhibit liver cancer growth.[12]

Structure and ligands

[edit]

The crystal structure of PNR's ligand-binding domain is known. It self-dimerizes into, by default, a repressor state. Computer simulations based on this model shows that a ligand could possibly fit into PNR and switch it into a transcription activator. 13-cis retinoic acid is a known weak agonist that fits into such a pocket, but no physiologic ligand is known. Two synthetic compounds, 11A and 11B, appear to be agonists but do not go into the pocket and instead work as allosteric modulators.[13] A more recent screening identifies another compound called photoregulin-1 (PR1) that functions as a reverse agonist, an activity possibly useful in the management of retinitis pigmentosa.[14]

Clinical significance

[edit]

Mutations in the NR2E3 gene have been linked to several inherited retinal diseases, including enhanced S-cone syndrome (ESCS),[15] a form of retinitis pigmentosa,[16] and Goldmann-Favre syndrome.[17]

By analyzing TCGA database and "All of Us" database, high expression of NR2E3 is associated with superior prognosis of cancer including breast cancer.[7][18] The mutation frequency of NR2E3 is higher in four types of cancer, such as colon cancer, than in the regular population.[7]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000278570Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000032292Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b Kobayashi M, Takezawa S, Hara K, Yu RT, Umesono Y, Agata K, et al. (April 1999). "Identification of a photoreceptor cell-specific nuclear receptor". Proceedings of the National Academy of Sciences of the United States of America. 96 (9): 4814–4819. Bibcode:1999PNAS...96.4814K. doi:10.1073/pnas.96.9.4814. PMC 21774. PMID 10220376.
  6. ^ Chen F, Figueroa DJ, Marmorstein AD, Zhang Q, Petrukhin K, Caskey CT, et al. (December 1999). "Retina-specific nuclear receptor: A potential regulator of cellular retinaldehyde-binding protein expressed in retinal pigment epithelium and Müller glial cells". Proceedings of the National Academy of Sciences of the United States of America. 96 (26): 15149–15154. Bibcode:1999PNAS...9615149C. doi:10.1073/pnas.96.26.15149. PMC 24788. PMID 10611353.
  7. ^ a b c d e Wang Y, Kroll TG, Hao L, Wen Z (January 2025). "Orphan nuclear receptor NR2E3 is a new molecular vulnerability in solid tumors by activating p53". Cell Death & Disease. 16 (1) 15. doi:10.1038/s41419-025-07337-1. PMC 11733144. PMID 39809731.
  8. ^ Milam AH, Rose L, Cideciyan AV, Barakat MR, Tang WX, Gupta N, et al. (January 2002). "The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration". Proceedings of the National Academy of Sciences of the United States of America. 99 (1): 473–478. doi:10.1073/pnas.022533099. PMC 117584. PMID 11773633.
  9. ^ Wen Z, Pyeon D, Wang Y, Lambert P, Xu W, Ahlquist P (January 2012). "Orphan nuclear receptor PNR/NR2E3 stimulates p53 functions by enhancing p53 acetylation". Molecular and Cellular Biology. 32 (1): 26–35. doi:10.1128/MCB.05513-11. PMC 3255696. PMID 22025681.
  10. ^ Wen Z, Bissonnette A, Moat LF, Wang Y, Katzenellenbogen BS, Katzenellenbogen JA, et al. (2024-11-05). "Nuclear Receptor NR2E3 Activates Both Wild-Type and Mutated p53 in Multiple Myeloma Cells". Blood. 144 (Supplement 1): 6840. doi:10.1182/blood-2024-199846. ISSN 0006-4971.
  11. ^ Zhao Z, Wang L, Wen Z, Ayaz-Guner S, Wang Y, Ahlquist P, et al. (2013). "Systematic analyses of the cytotoxic effects of compound 11a, a putative synthetic agonist of photoreceptor-specific nuclear receptor (PNR), in cancer cell lines". PLOS ONE. 8 (9) e75198. Bibcode:2013PLoSO...875198Z. doi:10.1371/journal.pone.0075198. PMC 3774666. PMID 24066170.
  12. ^ Leung YK, Lee SG, Wang J, Guruvaiah P, Rusch NJ, Ho SM, et al. (August 2024). "The Loss of an Orphan Nuclear Receptor NR2E3 Augments Wnt/β-catenin Signaling via Epigenetic Dysregulation that Enhances Sp1-β catenin-p300 Interactions in Hepatocellular Carcinoma". Advanced Science. 11 (29) e2308539. Weinheim, Baden-Wurttemberg, Germany. Bibcode:2024AdvSc..1108539L. doi:10.1002/advs.202308539. PMC 11304255. PMID 38790135.
  13. ^ Tan MH, Zhou XE, Soon FF, Li X, Li J, Yong EL, et al. (2013). "The crystal structure of the orphan nuclear receptor NR2E3/PNR ligand binding domain reveals a dimeric auto-repressed conformation". PLOS ONE. 8 (9) e74359. Bibcode:2013PLoSO...874359T. doi:10.1371/journal.pone.0074359. PMC 3771917. PMID 24069298.
  14. ^ Nakamura PA, Tang S, Shimchuk AA, Ding S, Reh TA (November 2016). "Potential of Small Molecule-Mediated Reprogramming of Rod Photoreceptors to Treat Retinitis Pigmentosa". Investigative Ophthalmology & Visual Science. 57 (14): 6407–6415. doi:10.1167/iovs.16-20177. PMC 5134355. PMID 27893103.
  15. ^ Haider NB, Jacobson SG, Cideciyan AV, Swiderski R, Streb LM, Searby C, et al. (February 2000). "Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate". Nature Genetics. 24 (2): 127–131. doi:10.1038/72777. PMID 10655056. S2CID 19508439.
  16. ^ Gerber S, Rozet JM, Takezawa SI, dos Santos LC, Lopes L, Gribouval O, et al. (September 2000). "The photoreceptor cell-specific nuclear receptor gene (PNR) accounts for retinitis pigmentosa in the Crypto-Jews from Portugal (Marranos), survivors from the Spanish Inquisition". Human Genetics. 107 (3): 276–284. doi:10.1007/s004390000350. hdl:10400.17/1708. PMID 11071390. S2CID 2774255.
  17. ^ Chavala SH, Sari A, Lewis H, Pauer GJ, Simpson E, Hagstrom SA, et al. (August 2005). "An Arg311Gln NR2E3 mutation in a family with classic Goldmann-Favre syndrome". The British Journal of Ophthalmology. 89 (8): 1065–1066. doi:10.1136/bjo.2005.068130. PMC 1772771. PMID 16024868.
  18. ^ Park YY, Kim K, Kim SB, Hennessy BT, Kim SM, Park ES, et al. (January 2012). "Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer". EMBO Molecular Medicine. 4 (1): 52–67. doi:10.1002/emmm.201100187. PMC 3376834. PMID 22174013.

Further reading

[edit]
[edit]